Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse - PubMed (original) (raw)

Review

. 2014 Jan 1;126(1):1-18.

doi: 10.1042/CS20120627.

Affiliations

• PMID: 24020444
• DOI: 10.1042/CS20120627

Review

Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse

Abhirup Jayasimhan et al. Clin Sci (Lond). 2014.

Abstract

T1D (Type 1 diabetes) is an autoimmune disease caused by the immune-mediated destruction of pancreatic β-cells. Studies in T1D patients have been limited by the availability of pancreatic samples, a protracted pre-diabetic phase and limitations in markers that reflect β-cell mass and function. The NOD (non-obese diabetic) mouse is currently the best available animal model of T1D, since it develops disease spontaneously and shares many genetic and immunopathogenic features with human T1D. Consequently, the NOD mouse has been extensively studied and has made a tremendous contribution to our understanding of human T1D. The present review summarizes the key lessons from NOD mouse studies concerning the genetic susceptibility, aetiology and immunopathogenic mechanisms that contribute to autoimmune destruction of β-cells. Finally, we summarize the potential and limitations of immunotherapeutic strategies, successful in NOD mice, now being trialled in T1D patients and individuals at risk of developing T1D.

PubMed Disclaimer

Similar articles

• The non-obese diabetic (NOD) mouse as a model of human type 1 diabetes.
  Kachapati K, Adams D, Bednar K, Ridgway WM. Kachapati K, et al. Methods Mol Biol. 2012;933:3-16. doi: 10.1007/978-1-62703-068-7_1. Methods Mol Biol. 2012. PMID: 22893397
• The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
  Pearson JA, Wong FS, Wen L. Pearson JA, et al. J Autoimmun. 2016 Jan;66:76-88. doi: 10.1016/j.jaut.2015.08.019. Epub 2015 Sep 26. J Autoimmun. 2016. PMID: 26403950 Free PMC article. Review.
• The NOD mouse: a model of immune dysregulation.
  Anderson MS, Bluestone JA. Anderson MS, et al. Annu Rev Immunol. 2005;23:447-85. doi: 10.1146/annurev.immunol.23.021704.115643. Annu Rev Immunol. 2005. PMID: 15771578 Review.
• Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
  Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Drescher KM, et al. Virology. 2004 Nov 24;329(2):381-94. doi: 10.1016/j.virol.2004.06.049. Virology. 2004. PMID: 15518817
• Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
  Serreze DV, Niens M, Kulik J, Dilorenzo TP. Serreze DV, et al. Methods Mol Biol. 2010;602:119-34. doi: 10.1007/978-1-60761-058-8_8. Methods Mol Biol. 2010. PMID: 20012396

Cited by

• NK Cells in Autoimmune Diseases: Protective or Pathogenic?
  Liu M, Liang S, Zhang C. Liu M, et al. Front Immunol. 2021 Mar 12;12:624687. doi: 10.3389/fimmu.2021.624687. eCollection 2021. Front Immunol. 2021. PMID: 33777006 Free PMC article. Review.
• Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.
  Motozono C, Pearson JA, De Leenheer E, Rizkallah PJ, Beck K, Trimby A, Sewell AK, Wong FS, Cole DK. Motozono C, et al. J Biol Chem. 2015 Jul 31;290(31):18924-33. doi: 10.1074/jbc.M114.622522. Epub 2015 Jun 17. J Biol Chem. 2015. PMID: 26085090 Free PMC article.
• Environmental Triggering of Type 1 Diabetes Autoimmunity.
  Houeiss P, Luce S, Boitard C. Houeiss P, et al. Front Endocrinol (Lausanne). 2022 Jul 22;13:933965. doi: 10.3389/fendo.2022.933965. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937815 Free PMC article. Review.
• Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes.
  Mullen Y. Mullen Y. Pancreas. 2017 Apr;46(4):455-466. doi: 10.1097/MPA.0000000000000828. Pancreas. 2017. PMID: 28291161 Free PMC article. Review.
• Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets.
  Alcazar O, Ogihara M, Ren G, Buchwald P, Abdulreda MH. Alcazar O, et al. Biomolecules. 2022 Oct 9;12(10):1444. doi: 10.3390/biom12101444. Biomolecules. 2022. PMID: 36291653 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information